Oncolines

Description

Oncolines provides precision medicine services in oncology and cancer immunotherapy, offering cell‑based assays, profiling platforms, bioinformatics, and combination‑screening workflows to identify patient selection markers and drug synergies.

Oncolines is located in the Netherlands ecosystem.

Related

• ZoBioZoBio helps biopharma companies identify small molecules for drug targets, applying protein-science expertise, biophysical and biochemical…
• Prevision MedicinePrevision Medicine tests living cancer and healthy cells from a patient biopsy against 100+ drugs and combinations using a patented ex vivo…
• EndoVia TherapeuticsEndoVia Therapeutics builds a precision oncology platform that combines tumor profiling and AI-driven digital twin models to predict,…
• CiMaasCiMaas develops immunotherapy products that expand and engineer natural killer (NK) cells for adoptive cell therapy and CAR‑NK applications…
• ORCA TherapeuticsORCA Therapeutics develops oncolytic virus immunotherapies for prostate cancer, producing lead candidate ORCA-010 for treatment‑naive…
• ToxysToxys provides in vitro toxicity screening assays and services, including ToxTracker and ReproTracker, for mechanistic genotoxicity and…
• Phlox TherapeuticsPhlox Therapeutics develops precision RNA-based therapies to treat rare genetic cardiomyopathies, creating therapeutic candidates and…
• Tessellate BioTessellate Bio discovers and develops precision oncology small-molecule medicines based on novel synthetic lethality interactions,…
• CCeraVxCeraVx develops ceramic CeraMaps microneedle patches for intradermal delivery of vaccines and medicines, using biocompatible, inert…